Translational Andrology and Urology is indexed in SCIE: a milestone for the development of TAU

On December 12, 2018, we received the good news from Clarivate Analytics (former Thomson Reuters Intellectual Property and Science Business) that Translational Andrology and Urology (TAU) has been indexed in Science Citation Index Expanded (SCIE) and articles published since 2016 will all be included.

TAU is the 8th journal of AME Publishing Company included by SCIE, following the other seven sister journals:

• ❖ Journal of Thoracic Disease (http://jtd.amegroups.com)

• ❖ Translational Cancer Research (http://tcr.amegroups.com)

• ❖ Annals of Translational Medicine (http://atm.amegroups.com)

• ❖ Hepatobiliary Surgery and Nutrition (http://hbsn.amegroups.com)

• ❖ Quantitative Imaging in Medicine and Surgery (http://qims.amegroups.com)

• ❖ Annals of Cardiothoracic Surgery (http://www.annalscts.com/)

• ❖ Translational Lung Cancer Research (http://tlcr.amegroups.com)

Led by Prof. Ying-Lu Guo and Prof. Tom F. Lue as the Editors-in-Chief, TAU is further supported by a strong lineup of over 70 experts worldwide in the field of andrology and urology as the Editorial Board members (Figure 1). TAU upholds AME’s philosophy and standards in running journals. It values the international diversity of Editorial Board members and authors (Figures 2,3) to ensure the quality of published articles. By publishing high-quality articles, TAU made lots of progress in the past six years, such as the article numbers (Figure 4), the growing citation and readers (Figures 5,6).

Figure 1.

A collage featuring the Editors-in-Chief and Editorial Board members of TAU.

Figure 2.

Geographical distribution of TAU’s Editorial Board members (updated on Dec. 12, 2018).

Figure 3.

Geographical distribution of TAU’s Corresponding Authors in 2018 (updated on Dec. 12, 2018).

Figure 4.

Number of published articles (updated on Dec. 12, 2018).

Figure 5.

Citation of TAU articles by articles indexed in Web of Science Core Collection (data were collected from Web of Science Core Collection on Dec. 13, 2018).

Figure 6.

Retrieval of TAU in PubMed is increasing and it also presents the growing readers of TAU (data were collected from PMC Publisher Services on Nov. 30, 2018).

Speaking of high-quality articles, we also would like to take this chance to extend our heartfelt gratitude to another group of experts—our Guest Editors, who have been actively involved in the forefront of scientific research and clinical practice and devoted their precious time and effort to organize the excellent focused issues (Tables 1,2) to demonstrate the cutting-edge knowledge, techniques, and discussions in their professional fields to our readers.

Table 1. List of published focused issues and guest editors.

No.	Issue	Topic of published issue	Guest editor	Affiliation	Country
1	V2N1	Men’s Health	Run Wang	University of Texas Health Science Center, McGovern Medical School at Houston	USA
2	V2N3	Prostate Cancer	Jer-Tsong Hsieh	University of Texas Southwestern Medical Center	USA
			Ganesh Raj	University of Texas Southwestern Medical Center	USA
3	V3N1	Male infertility, Microsurgery and Men’s Health	Philip S. Li	Weill Cornell Medical College	USA
			Marc Goldstein	Weill Cornell Medical College	USA
4	V3N2	Male Genitourinary Reconstruction and Trauma	Benjamin N. Breyer	University of California, San Francisco	USA
			Jack W. McAninch	University of California, San Francisco	USA
5	V3N3	Kidney Stone Disease	Thomas Chi	University of California, San Francisco	USA
			Marshall L. Stoller	University of California, San Francisco	USA
6	V3N4	Pediatric Urology	Laurence S. Baskin	UCSF Children’s Hospital	USA
			Barry A. Kogan	Albany Medical College	USA
7	V4N1	Contemporary Management of Urethral Stricture	Jay Simhan	Fox Chase/Einstein Urologic Institute	USA
			Allen F. Morey	University of Texas Southwestern Medical Center	USA
8	V4N2	Cancer and Sexual Health	Luca Incrocci	Erasmus MC Cancer Institute	The Netherlands
9	V4N3	Urological Oncology	George N. Thalmann	University of Bern, Inselspital	Switzerland
10	V4N5 & V4N6	Interstitial Cystitis/Painful Bladder Syndrome	Grannum R. Sant	Tufts University School of Medicine	USA
			Ricardo Saban	University Anhembi Morumbi	Brazil
11	V5N1	Controversies and Current Management of Adult Neurogenic Bladder	Jeremy B. Myers	University of Utah	USA
			John T. Stoffel	University of Michigan Health System	USA
			Blayne Welk	Western University, Ontario	Canada
			Sean Elliott	University of Minnesota	USA
12	V5N2	Current Topics in Men’s Health	Charles Welliver	Albany Medical College	USA
			Tobias S. Köhler	Mayo Clinic	USA
			Kevin T. McVary	Loyola University Medical Center	USA
13	V5N3	Peyronie’s Disease	Wayne JG. Hellstrom	Tulane University School of Medicine	USA
			Faysal A. Yafi	University of California Irvine	USA
14	V5N4	Ejaculatory Dysfunction	Chris G. McMahon	Australian Centre for Sexual Health	Australia
15	V5N5	Urothelial Carcinoma	Shahrokh F. Shariat	Medical University of Vienna	Austria
			Romain Mathieu	Rennes University Hospital	France
16	V5N6	Testosterone Replacement Therapy	Daniel A. Shoskes	The Glickman Urological and Kidney Institute and Cleveland Clinic	USA
			Lawrence S. Hakim	Cleveland Clinic Florida	USA
17	V6N1	Erectile Dysfunction	Gerald Brock	University of Western Ontario	Canada
			Eric Chung	St Andrew's War Memorial Hospital	Australia
18	V6S1	Chronic Orchialgia	Ryan P. Smith	University of Virginia	USA
			Raymond A. Costabile	University of Virginia	USA
19	V6N2	Global Urology	Gopal H. Badlani	Wake Forest University Baptist Medical Center	USA
			Sakti Das	University of California Davis School of Medicine	USA
20	V6N3	Magnetic Resonance Imaging in Prostate Cancer	Marc A. Bjurlin	NYU Langone Medical Center	USA
			Andrew B. Rosenkrantz	NYU Langone Medical Center	USA
			Herbert Lepor	NYU Langone Medical Center	USA
			Samir S. Taneja	NYU Langone Medical Center	USA
21	V6S2	Functional Urology	Johan Gani	Austin Health and Western Health	Australia
			Helen E. O’Connell	The University of Melbourne	Australia
22	V6N4	Technique and Complications from the Masters in Andrologic Surgery	Tobias S. Köhler	Mayo Clinic	USA
23	V6S4	Sperm DNA Fragmentation	Ashok Agarwal	American Center for Reproductive Medicine, Urological Institute, Cleveland Clinic	USA
			Chak-Lam Cho	Union Hospital, Hong Kong	China
			Ahmad Majzoub	Hamad Medical Corporation and Weill Cornell Medicine-Qatar	Qatar
			Sandro C. Esteves	ANDROFERT, Andrology and Human Reproduction Clinic	Brazil
24	V6N5	Management of Penile Cancer	Philippe E. Spiess	Moffitt Cancer Center	USA
			Michael A. Poch	Moffitt Cancer Center	USA
25	V6S5	Penile Prosthesis and Penile Implants	Jason R. Kovac	Men's Health Center, Indianapolis	USA
26	V6N6	Bladder Cancer: Genetics and Biomarker for Optimized Clinical Decision-making and Improved Outcomes	Michael Rink	University Medical Center Hamburg-Eppendorf	Germany
27	V7N1	Prostate Cancer Screening and Active Surveillance in the Western World	Monique J. Roobol	Erasmus University Medical Center	The Netherlands
28	V7N2	Active Surveillance for Prostate Cancer	Marc A. Dall'Era	University of California, Davis	USA
			Benjamin Davies	University of Pittsburgh School of Medicine	USA
			Scott Eggener	University of Chicago Medicine	USA
29	V7N3	Radiation Therapy for Prostate Cancer	Mark Buyyounouski	Stanford University	USA
30	V7S3	Knowledge gaps in male infertility	James M. Hotaling	University of Utah	USA
			Ranjith Ramasamy	University of Miami Miller School of Medicine	USA
31	V7N4	Male Genitourinary Reconstruction and Trauma	Benjamin N. Breyer	University of California, San Francisco	USA
			E. Charles Osterberg	Dell Medical School at The University of Texas	USA
32	V7S4	Personalized Prostate Cancer Care	Soroush Rais-Bahrami	University of Alabama at Birmingham	USA
			Jennifer B. Gordetsky	University of Alabama at Birmingham	USA
33	V7N5	Detection of Lymph Node Metastases in Genitourinary Cancers	Baris Turkbey	National Cancer Institute, NIH	USA

Table 2. List of upcoming focused issues and guest editors.

No.	Topic of upcoming issue	Guest editor	Affiliation	Country
1	Organ Transplantation in Urology	Daniel Shoskes	Glickman Urological and Kidney Institute, Cleveland Clinic Foundation	USA
2	Current Management of Non-muscle Invasive Badder Cancer	Evanguelos Xylinas	Paris Descartes University	France
		Florian Roghmann	Ruhr University Bochum, Marien Hospital	Germany
		Marco Moschini	Luzerner Kantonsspital-Luzern	Switzerland
3	Kidney Disease	Glenda Gobe	University of Queensland	Australia
4	Urologic Management of the Transgender Patient	Sean Elliott	University of Minnesota	USA
		Joseph J Pariser	University of Minnesota	USA
		Lee Zhao	NYU Langone Medical Center, New York University School of Medicine	USA
5	Minimally Invasive Treatments for Kidney Stones	Bhaskar Somani	University Hospital Southampton NHS Trust	UK
6	Testicular Cancer	Wade J. Sexton	Moffitt Cancer Center	USA
		Scott M. Gilbert	Moffitt Cancer Center	USA
7	Controversies in Minimally Invasive Urologic Oncology	Marc C. Smaldone	Fox Chase Cancer Center, Temple University Health System	USA
		Jeffrey J. Tomaszewski	MD Anderson Cancer Center at Cooper, Cooper Medical School of Rowan University	USA
8	Current Topics of Reconstructive Urologic Surgery	Allen F. Morey	University of Texas Southwestern Medical Center	USA
		Boyd R. Viers	Mayo Clinic	USA
9	Contemporary Issues in Men’s Health	Larry I. Lipshultz	Baylor College of Medicine	USA
		Alexander W. Pastuszak	University of Utah	USA

Moreover, there are still our Section Editors, Reviewers and Readers worldwide that we could not express our appreciation one by one.

Currently, TAU is indexed in PubMed/PubMed Central, Scopus and SCIE. We can’t achieve this without the continuous support and contributions of TAU’s editorial board members, guest editors, authors, reviewers and readers. We here would like to extend our sincere gratitude to all the contributors. We will keep striving to publish high-quality articles and make TAU to the forefront in the field of andrology and urology.